Personnel Today
  • OHW+
  • Resources
    • Clinical governance
    • Disability
    • Ergonomics
    • Health surveillance
    • OH employment law
    • OH service delivery
    • Research
    • Return to work and rehabilitation
    • Sickness absence management
    • Wellbeing and health promotion
  • Conditions
    • Mental health
    • Musculoskeletal disorders
    • Blood pressure
    • Cancer
    • Cardiac
    • Dementia
    • Diabetes
    • Respiratory
    • Stroke
  • CPD
  • Webinars
  • Jobs
  • Personnel Today

Register
Log in
Personnel Today
  • OHW+
  • Resources
    • Clinical governance
    • Disability
    • Ergonomics
    • Health surveillance
    • OH employment law
    • OH service delivery
    • Research
    • Return to work and rehabilitation
    • Sickness absence management
    • Wellbeing and health promotion
  • Conditions
    • Mental health
    • Musculoskeletal disorders
    • Blood pressure
    • Cancer
    • Cardiac
    • Dementia
    • Diabetes
    • Respiratory
    • Stroke
  • CPD
  • Webinars
  • Jobs
  • Personnel Today

Fit for WorkResearchDisabilityReturn to work and rehabilitationSickness absence management

Study suggests Epstein-Barr virus could be trigger for multiple sclerosis

by Nic Paton 19 May 2023
by Nic Paton 19 May 2023 Scientists have narrowed in on the links between the Epstein-Barr virus and the deilitating neurological condition multiple sclerosis.
Image: Shutterstock
Scientists have narrowed in on the links between the Epstein-Barr virus and the deilitating neurological condition multiple sclerosis.
Image: Shutterstock

A common childhood virus could be an important trigger for multiple sclerosis (MS) in later life, research has suggested.

The finding, which could be a platform for the development of new treatments for the condition, has been published in the journal Science Advances.

The research, led by Dr Olivia Thomas of Sweden’s Karolinska Institute, has suggested the body’s immune response to the Epstein-Barr virus (EBV), a normally harmless infection, can misfire and mistakenly target a crucial protein in the brain and spinal cord.

EBV infects most people early in life and then remains in the body, usually without causing symptoms. The link between EBV and MS was discovered many years ago and has long puzzled researchers.

The latest research builds on two papers published in the journals Science and Nature last year. These suggested EBV infection could precede MS and that antibodies against the virus could be involved. Those infected with EBV were 32 times more likely to develop MS, they concluded. However, the molecular mechanisms appeared to vary between patients and remained largely unknown.

Multiple sclerosis

OH the key to helping employers understand, and support, less well-known conditions

Poor at greater risk of developing multiple sclerosis

“MS is an incredibly complex disease, but our study provides an important piece in the puzzle and could explain why some people develop the disease,” said Dr Thomas, postdoctoral researcher in the institute’s Department of Clinical Neuroscience.

“We have discovered that certain antibodies against the Epstein-Barr virus, which would normally fight the infection, can mistakenly target the brain and spinal cord and cause damage.”

The researchers analysed blood samples from more than 700 patients with MS and 700 healthy individuals.

They found that antibodies that bind to a certain protein in the Epstein-Barr virus, called EBNA1, can also bind to a similar protein in the brain and spinal cord called CRYAB, whose role is to prevent protein aggregation during conditions of cellular stress such as inflammation.

These misdirected, cross-reactive antibodies may damage the nervous system and cause severe symptoms in MS patients, including problems with balance, mobility and fatigue. The antibodies were present in about 23% of MS patients yet only 7% of control individuals.

“This shows that, whilst these antibody responses are not required for disease development, they may be involved in disease in up to a quarter of MS patients,” said Dr Thomas. “This also demonstrates the high variation between patients, highlighting the need for personalised therapies. Current therapies are effective at reducing relapses in MS but unfortunately, none can prevent disease progression.”

Sign up to our weekly round-up of HR news and guidance

Receive the Personnel Today Direct e-newsletter every Wednesday

OptOut
This field is for validation purposes and should be left unchanged.

The researchers also found that there is likely a similar cross-reactivity among T cells of the immune system.

“We are now expanding our research to investigate how T cells fight EBV infection and how these immune cells may damage the nervous system in multiple sclerosis and contribute to disease progression,” said Mattias Bronge, affiliated researcher at the institute’s Department of Clinical Neuroscience.

Nic Paton

Nic Paton is consultant editor at Personnel Today. One of the country's foremost workplace health journalists, Nic has written for Personnel Today and Occupational Health & Wellbeing since 2001, and edited the magazine from 2018.

previous post
Patients with obesity cost NHS twice as much
next post
Union warns Asda over mooted pay cuts

You may also like

First ‘game-changing’ new treatment for asthma attacks in...

29 Nov 2024

Better reporting needed as scale of workplace harm...

31 Oct 2024

Ditching two-child benefit gap would narrow health inequalities...

12 Aug 2024

Study links ‘forever chemicals’ with cardiovascular deaths

8 May 2024

More stimulating work can protect against later-life dementia

22 Apr 2024

Work underway to develop lung cancer vaccine

25 Mar 2024

Tube workers exposed to fine dust take more...

22 Mar 2024

Academics working with energy-limiting conditions sought for study

15 Feb 2024

Study: Night shift workers need weight management support

30 Nov 2023

Pandemic affected long-term brain health

3 Nov 2023

  • 2025 Employee Communications Report PROMOTED | HR and leadership...Read more
  • The Majority of Employees Have Their Eyes on Their Next Move PROMOTED | A staggering 65%...Read more
  • Prioritising performance management: Strategies for success (webinar) WEBINAR | In today’s fast-paced...Read more
  • Self-Leadership: The Key to Successful Organisations PROMOTED | Eletive is helping businesses...Read more
  • Retaining Female Talent: Four Ways to Reduce Workplace Drop Out PROMOTED | International Women’s Day...Read more

PERSONNEL TODAY

About us
Contact us
Browse all HR topics
Email newsletters
Content feeds
Cookies policy
Privacy policy
Terms and conditions

JOBS

Personnel Today Jobs
Post a job
Why advertise with us?

EVENTS & PRODUCTS

The Personnel Today Awards
The RAD Awards
Employee Benefits
Forum for Expatriate Management
OHW+
Whatmedia

ADVERTISING & PR

Advertising opportunities
Features list 2025

  • Facebook
  • Twitter
  • Instagram
  • Linkedin


© 2011 - 2025 DVV Media International Ltd

Personnel Today
  • OHW+
  • Resources
    • Clinical governance
    • Disability
    • Ergonomics
    • Health surveillance
    • OH employment law
    • OH service delivery
    • Research
    • Return to work and rehabilitation
    • Sickness absence management
    • Wellbeing and health promotion
  • Conditions
    • Mental health
    • Musculoskeletal disorders
    • Blood pressure
    • Cancer
    • Cardiac
    • Dementia
    • Diabetes
    • Respiratory
    • Stroke
  • CPD
  • Webinars
  • Jobs
  • Personnel Today